Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
Emma J HeymerMichael M HawkinsDavid L WinterJop C TeepenCeren SungucCecile M RonckersRodrigue Setcheou AllodjiDaniela AlessiElaine SugdenFabiën N BelleFrancesca BagnascoJulianne ByrneEdit BárdiStanislaw GarwiczDesiree GrabowMomcilo JankovicPeter KaatschMelanie KaiserGisela MichelChristina SchinderaNadia HaddyNeige JournyMaja Česen MazićRoderick SkinnerJudith L KokMaria W GunnesThomas WiebeCarlotta SacerdoteMilena Maria MauleMonica TerenzianiZsuzsanna JakabJeanette Falck WintherPäivi Maria LähteenmäkiLorna Zadravec ZaletelRiccardo HauptClaudia Elisabeth KuehniLeontien C KremerFlorent de VathaireLars HjorthRaoul C ReulenPublished in: British journal of cancer (2024)
Clinicians following up survivors should be aware that the substantial risks of meningioma and glioma following CRT are sustained beyond age 40 and be vigilant for symptoms.